Despite progress in understanding the underlying mechanisms, acute liver failure (ALF) is still one of the major clinical challenges in hepatology.

Scientists at Cold Spring Harbor Laboratory (CSHL) have reported a discovery that they hope will lead to the development of a powerful new way of…

Liver transplantation for alcoholic liver disease (ALD) is controversially discussed. Although overall survival after liver transplantation is similar to…

Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients.

The hepatitis B virus (HBV) causes infection in the liver that can lead to cirrhosis, liver cancer, and premature death. The disease is not widely…

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and it is expected to rise even further as a result of the…

Non-alcoholic fatty liver disease (NAFLD) is a cluster of pathological liver conditions of emerging importance in overweight and obese children.

Alternatives for liver transplantation in severe liver disease are urgently needed in view of the limited availability of donor livers.

This Bristol Myers Squibb-sponsored symposium was chaired by Mark Thursz, who oversaw a novel news bulletin-themed symposium with sessions provided by a …

This Gilead-sponsored satellite symposium addressed the new and exciting advent of novel therapy in the field of hepatitis C by highlighting recent…